Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. MediPal Holdings Corporation
  6. News
  7. Summary
    7459   JP3268950007

MEDIPAL HOLDINGS CORPORATION

(7459)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Heartseed Inc. announced that it has received ¥4 billion in funding from a group of investors

06/11/2021 EDT

Heartseed Inc. announced that it has received $37 million (¥4 billion) in Series C round of funding on June 11, 2021. The transaction included participation from new investor UTokyo Innovation Platform Co., Ltd., Medical Incubator Japan K.K., Keio Innovation Initiative Inc., Sumitomo Mitsui Trust Investment Co., Ltd., existing investors SBI Investment Co., Ltd., Nissay Capital Co., Ltd., SMBC Venture Capital Co., Ltd., MediPal Holdings Corporation (TSE:7459), ITOCHU CHEMICAL FRONTIER Corporation. The company has raised $75 million (¥8.2 billion) in funding till date.


© S&P Capital IQ 2021
All news about MEDIPAL HOLDINGS CORPORATION
09/02Nichi-Iko Pharmaceutical Co., Ltd. announced that it has received ¥5.23102 bi..
CI
08/17Nichi-Iko Pharmaceutical Co., Ltd. announced that it expects to receive ¥5.23..
CI
08/10Orizuru Therapeutics Inc. announced that it has received funding from Kyoto U..
CI
06/11Heartseed Inc. announced that it has received ¥4 billion in funding from a gr..
CI
03/30MEDIPAL HOLDINGS CORPORATION : Ex-dividend day for final dividend
FA
02/16CARADA medica Inc. announced that it expects to receive ¥6.157 billion in fun..
CI
2020MEDIPAL HOLDINGS CORPORATION : Ex-dividend day for interim dividend
FA
2020CRYOPORT : MEDIPAL HOLDINGS Partners with CRYOPORT to Bring Temperature-Controll..
AQ
2020MediPal Holdings Corporation Partners with Cryoport, Inc. to Bring Temperatur..
CI
2020MEDIPAL HOLDINGS CORPORATION : Ex-dividend day for final dividend
FA
More news
Financials
Sales 2022 3 265 B 29 675 M 29 675 M
Net income 2022 31 483 M 286 M 286 M
Net Debt 2022 - - -
P/E ratio 2022 15,3x
Yield 2022 1,90%
Capitalization 469 B 4 265 M 4 260 M
Capi. / Sales 2022 0,14x
Capi. / Sales 2023 0,14x
Nbr of Employees 12 971
Free-Float 75,4%
Chart MEDIPAL HOLDINGS CORPORATION
Duration : Period :
MediPal Holdings Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDIPAL HOLDINGS CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 6
Last Close Price 2 232,00 JPY
Average target price 2 216,67 JPY
Spread / Average Target -0,69%
EPS Revisions
Managers and Directors
Shuichi Watanabe President & Representative Director
Kunie Yamazaki Senior Executive Officer & Head-Compliance
Yuji Sakon Managing Director & General Manager-Administration
Mitsuko Kagami Independent Outside Director
Kuniko Shoji Independent Director
Sector and Competitors